Dolatkhah R, Somi MH, Kermani IA et al.
Hematology and Oncology Research Center Tabriz University of Medical Sciences Tabriz Iran.
Clinical case reports. Mar 2017.
While the role of KRAS gene mutations has been widely accepted for predicting responses to anti-EGFR therapy in patients with colorectal cancer, although this study was based on observation of a single case it gives hope that some KRAS gene mutation may have favorable prognosis. More studies are required on patients with similar mutation to validate this finding.